her2climb-04: tucatinib trastuzumab deruxtecan in her2 breast cancer
Published 3 years ago • 175 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:16
her2climb-04: tucatinib plus t-dxd for her2 breast cancer
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer
-
2:01
her2climb: tucatinib in combination w/ capecitabine & trastuzumab
-
1:47
her2climb-05: tucatinib trastuzumab and pertuzumab as maintenance therapy for her2 metastatic bc
-
12:41
her2climb-02 study data assesses trastuzumab plus tucatinib in patients with her2 breast cancer
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
1:05
efficacy of trastuzumab deruxtecan in her2-low metastatic breast cancer
-
5:50
her2climb: investigating tucatinib with capecitabine and trastuzumab in her2-positive metastatic...
-
1:14
updated analysis from mountaineer: tucatinib and trastuzumab for her2-positive mcrc
-
0:52
the significance of tucatinib trastuzumab as a chemotherapy-free option for her2 metastatic btc
-
1:12
trastuzumab deruxtecan in metastatic her2 breast cancer
-
1:24
tucatinib and trastuzumab in the treatment paradigm of her2-positive mcrc
-
3:15
her2climb-02: tucatinib tdm-1 in advanced breast cancer
-
2:15
treatment strategies for her2 metastatic breast cancer
-
1:30
tucatinib in her2 breast cancer with leptomeningeal metastases
-
2:29
mountaineer: tucatinib plus trastuzumab for her2 metastatic colorectal cancer
-
0:36
tucatinib & trastuzumab /- chemo or pembrolizumab in unresectable or metastatic her2 gi cancers